Showing results (901-910 of 13,572) with videos related to

Sort By:
Pageof 1,358
Hypertension (Dallas, Tex. : 1979)|June 17, 2000
Physiology and pathophysiology of the adipose tissue renin-angiotensin systemS Engeli, R Negrel, A M Sharma
Hypertension (Dallas, Tex. : 1979)|June 17, 2000
Lack of association of 3 functional gene variants with hypertension in African AmericansN Larson, R Hutchinson, E Boerwinkle
Hypertension (Dallas, Tex. : 1979)|February 19, 1999
NaCl-induced renal vasoconstriction in salt-sensitive African Americans: antipressor and hemodynamic effects of potassium bicarbonateO Schmidlin, A Forman, M Tanaka, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 1999
The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trialsS H Jee, J He, P K Whelton, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 1999
Effects of amlodipine on sympathetic nerve traffic and baroreflex control of circulation in heart failureG Grassi, D Spaziani, G Seravalle, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 1999
Genetic and gender influences on sensitivity to focal cerebral ischemia in the stroke-prone spontaneously hypertensive ratH V Carswell, N H Anderson, J S Clark, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 1999
Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuriaR Largo, D Gómez-Garre, K Soto, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 1999
Role of endothelin in the increased vascular tone of patients with essential hypertensionC Cardillo, C M Kilcoyne, M Waclawiw, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 1999
Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in ratsY Matsumura, N Hashimoto, S Taira, et al.
Hypertension (Dallas, Tex. : 1979)|November 18, 2000
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study InvestigatorsP M Okin, R B Devereux, S Jern, et al.
Pageof 1,358